NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

OPRX

OptimizeRx Corp

Jul 03 • 12:40PM ET

13.40

Dollar change +0.28
Percentage change 2.13	%

Healthcare • Health Information Services • USA • NASD

Peers: TDOC VEEV HSTM GDRX PEGA OTLK HIMX HUT DHX

| Held by: VTI IWM VXF IWO VTWO JSML DFAT DFAS IWC AVSC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.84	Insider Own	9.41%	Shs Outstand	18.49M	Perf Week	5.93%
Market Cap	247.84M	Forward P/E	20.18	EPS next Y	0.66	Insider Trans	22.65%	Shs Float	16.75M	Perf Month	1.36%
Enterprise Value	264.07M	PEG	-	EPS next Q	0.02	Inst Own	64.17%	Short Float	9.37%	Perf Quarter	60.86%
Income	-15.41M	P/S	2.63	EPS this Y	66.91%	Inst Trans	2.92%	Short Ratio	5.37	Perf Half Y	153.79%
Sales	94.37M	P/B	2.13	EPS next Y	20.53%	ROA	-8.95%	Short Interest	1.57M	Perf YTD	175.72%
Book/sh	6.29	P/C	14.96	EPS next 5Y	-	ROE	-12.90%	52W High	15.71 -14.70%	Perf Year	34.13%
Cash/sh	0.90	P/FCF	36.55	EPS past 3/5Y	- -36.18%	ROIC	-10.58%	52W Low	3.78 254.50%	Perf 3Y	-53.05%
Dividend Est.	-	EV/EBITDA	251.49	Sales past 3/5Y	14.55% 30.23%	Gross Margin	59.52%	Volatility	5.42% 6.92%	Perf 5Y	-0.37%
Dividend TTM	-	EV/Sales	2.80	EPS Y/Y TTM	17.97%	Oper. Margin	-3.50%	ATR (14)	0.81	Perf 10Y	233.33%
Dividend Ex-Date	-	Quick Ratio	2.82	Sales Y/Y TTM	20.66%	Profit Margin	-16.33%	RSI (14)	53.85	Recom	1.29
Dividend Gr. 3/5Y	- -	Current Ratio	2.82	EPS Q/Q	68.66%	SMA20	-2.77%	Beta	1.34	Target Price	16.17
Payout	-	Debt/Eq	0.28	Sales Q/Q	11.37%	SMA50	12.34%	Rel Volume	0.35	Prev Close	13.12
Employees	129	LT Debt/Eq	0.25	Earnings	May 12 AMC	SMA200	75.43%	Avg Volume	292.59K	Price	13.40
IPO	May 18, 2005	Option/Short	Yes / Yes	EPS/Sales Surpr.	166.67% 17.35%	Trades		Volume	51,783	Change	2.13%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$7 → $6
Dec-20-24	Initiated	Stephens	Equal-Weight	$5.50
Jul-25-24	Resumed	B. Riley Securities	Buy	$18.50
Apr-04-24	Initiated	JMP Securities	Mkt Outperform	$15
Jan-03-24	Initiated	Barclays	Equal Weight	$15
Feb-02-23	Resumed	B. Riley Securities	Buy	$30
Nov-01-22	Initiated	Stifel	Buy	$19
Jul-15-22	Initiated	SVB Leerink	Outperform	$38
Oct-18-21	Resumed	B. Riley Securities	Buy	$102
Apr-13-21	Initiated	RBC Capital Mkts	Outperform	$65
Jan-03-19	Initiated	William Blair	Outperform

Show Previous Ratings

Today 10:33AM	OPRX Shares Rise 69.3% in 3 Months: Time to Bet on the Stock? (Zacks)
Jun-25-25 07:41AM	Best Growth Stocks to Buy for June 25th (Zacks)
Jun-24-25 07:30AM	OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors (GlobeNewswire)
Jun-20-25 10:13AM	Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions (Business Wire)
Jun-18-25 03:00AM	Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions (Business Wire)
12:00PM	Loading…
Jun-06-25 12:00PM	Here's Why OptimizeRx Corp. (OPRX) is a Great Momentum Stock to Buy (Zacks)
Jun-04-25 05:52AM	New Strong Buy Stocks for June 4th (Zacks)
May-23-25 10:54AM	DSGX's Solution Used by ArrowXL to Boost Last Mile Delivery (Zacks)
May-22-25 12:20PM	Earnings Estimates Rising for OptimizeRx (OPRX): Will It Gain? (Zacks)
May-16-25 07:30AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire) +7.32%
May-13-25 08:08AM	Q1 2025 OptimizeRx Corp Earnings Call (Thomson Reuters StreetEvents) +19.67%
03:08AM	OptimizeRx Corp (OPRX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts (GuruFocus.com)
May-12-25 05:35PM	OptimizeRx Corp. (OPRX) Beats Q1 Earnings and Revenue Estimates (Zacks) -7.91%
04:05PM	OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance (GlobeNewswire)
May-09-25 09:43AM	Earnings To Watch: OptimizeRx Corp (OPRX) Reports Q1 2025 Result (GuruFocus.com)
04:05PM	Loading…
May-01-25 04:05PM	OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report (GlobeNewswire) +5.70%
Apr-30-25 05:15PM	Microsoft (MSFT) Q3 Earnings and Revenues Beat Estimates (Zacks)
Apr-28-25 05:15PM	Cadence Design Systems (CDNS) Beats Q1 Earnings and Revenue Estimates (Zacks) +5.03%
Apr-23-25 07:30AM	OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET (GlobeNewswire)
Apr-18-25 04:15PM	OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment (GlobeNewswire)
Mar-17-25 08:31AM	Why OptimizeRx Corp. (OPRX) Soared Last Week? (Insider Monkey) +6.44%
Mar-13-25 03:03AM	OptimizeRx Corp (OPRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Margin Expansion (GuruFocus.com) +13.85%
01:25AM	Q4 2024 OptimizeRx Corp Earnings Call (Thomson Reuters StreetEvents)
Mar-12-25 08:45AM	OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates (Zacks) +51.69%
07:30AM	OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-11-25 07:30AM	OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations (GlobeNewswire)
Mar-10-25 07:30AM	OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer (GlobeNewswire) -6.11%
Feb-27-25 07:30AM	OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET (GlobeNewswire)
Feb-05-25 01:36PM	Whetstone Capital Discloses 8.2% Stake in OptimizeRx, Urges Strategic Alternatives (GuruFocus.com)
Jan-08-25 08:37AM	OptimizeRx downgraded to "sector perform" by RBC amid slower growth outlook (Investing.com) -7.04%
09:05AM	Loading…
Dec-25-24 09:05AM	OptimizeRx price target lowered to $13 from $17 at B. Riley (TipRanks)
08:40AM	Lake Street reiterates Buy on OptimizeRx after surprising CEO departure (TipRanks)
Dec-23-24 08:45AM	OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO (GlobeNewswire)
Nov-18-24 07:30AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire) +9.80%
Nov-14-24 02:15AM	OptimizeRx Corp (OPRX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Shifts ... (GuruFocus.com) -33.98%
Nov-13-24 05:35PM	OptimizeRx Corp. (OPRX) Surpasses Q3 Earnings Estimates (Zacks) +5.31%
04:05PM	OptimizeRx Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-07-24 09:12AM	OptimizeRx (OPRX) Surges 19.8%: Is This an Indication of Further Gains? (Zacks)
Oct-31-24 07:30AM	OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET (GlobeNewswire)
Oct-03-24 04:25AM	OptimizeRx (OPRX) Moves 5.4% Higher: Will This Strength Last? (Zacks)
Sep-10-24 07:30AM	OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value (GlobeNewswire)
Sep-09-24 12:00PM	OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences (GlobeNewswire)
Sep-04-24 09:35AM	Down -12.46% in 4 Weeks, Here's Why OptimizeRx (OPRX) Looks Ripe for a Turnaround (Zacks)
Aug-08-24 06:25PM	OptimizeRx Corp. (OPRX) Tops Q2 Earnings Estimates (Zacks) +6.88% -5.31%
04:05PM	OptimizeRx Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-01-24 10:01AM	OptimizeRx Corp. (OPRX) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Jul-25-24 07:30AM	OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET (GlobeNewswire)
Jul-23-24 07:30AM	OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation (GlobeNewswire)
Jul-15-24 07:30AM	OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients (GlobeNewswire)
Jun-20-24 07:30AM	New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations (GlobeNewswire)
May-14-24 08:56PM	OPRX Stock Earnings: OptimizeRx Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +25.67%
04:01PM	OptimizeRx Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-13-24 09:55AM	Does OptimizeRx (OPRX) Have the Potential to Rally 34.78% as Wall Street Analysts Expect? (Zacks)
May-06-24 04:30PM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire)
Apr-26-24 07:30AM	OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET (GlobeNewswire) +15.00%
Apr-23-24 09:35AM	After Plunging -22.84% in 4 Weeks, Here's Why the Trend Might Reverse for OptimizeRx (OPRX) (Zacks)
Apr-22-24 09:35AM	Down -18.75% in 4 Weeks, Here's Why You Should You Buy the Dip in OptimizeRx (OPRX) (Zacks)
Apr-18-24 07:30AM	OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report (GlobeNewswire)
Apr-16-24 07:00AM	OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Apr-11-24 07:30AM	OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row (GlobeNewswire)
Apr-06-24 06:00AM	7 Top Undervalued Stocks Primed for a Multibagger Recovery (InvestorPlace)
Apr-01-24 03:02PM	OptimizeRx Corporation (NASDAQ:OPRX) Q4 2023 Earnings Call Transcript (Insider Monkey) -6.01%
Mar-28-24 09:54PM	OPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023 (InvestorPlace)
Mar-25-24 07:30AM	OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET (GlobeNewswire)
Mar-11-24 04:30PM	OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023 (GlobeNewswire) -14.12%
Mar-04-24 03:51PM	OptimizeRx Powers Walmart's 'Specialty Pharmacies of the Community' Outreach Effort (GlobeNewswire)
Feb-21-24 07:30AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jan-25-24 07:30AM	OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape (GlobeNewswire)
Jan-09-24 07:30AM	OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update (GlobeNewswire) +13.85%
Dec-26-23 06:19AM	Should You Exit OptimizeRx Corp. (OPRX)? (Insider Monkey)
Dec-18-23 07:30AM	OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco (GlobeNewswire) +5.98%
Dec-11-23 12:00PM	OptimizeRx Corp. (OPRX) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Dec-06-23 09:55AM	Wall Street Analysts Predict a 41.25% Upside in OptimizeRx Corp. (OPRX): Here's What You Should Know (Zacks)
Nov-21-23 12:20PM	Why OptimizeRx Corp. (OPRX) Might be Well Poised for a Surge (Zacks)
Nov-20-23 09:55AM	How Much Upside is Left in OptimizeRx Corp. (OPRX)? Wall Street Analysts Think 47.72% (Zacks)
Nov-13-23 11:38AM	OptimizeRx Corporation (NASDAQ:OPRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 02:17AM	Q3 2023 OPTIMIZERx Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-06-23 08:17AM	OptimizeRx Corp (OPRX) Reports Q3 2023 Earnings, Raises 2023 Guidance and Introduces 2024 Guidance (GuruFocus.com) +15.31%
07:00AM	OptimizeRx Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-30-23 10:00AM	OptimizeRx Corp. (OPRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-25-23 07:30AM	OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET (GlobeNewswire) -5.14%
Oct-13-23 03:59AM	OptimizeRx Corp. (OPRX) Surges 13.0%: Is This an Indication of Further Gains? (Zacks) +5.07%
Oct-12-23 07:00AM	OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers (GlobeNewswire) +13.01%
Sep-26-23 08:00AM	OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform (GlobeNewswire)
Aug-24-23 08:00AM	OptimizeRx Expands AI Powered Omnichannel Platform (GlobeNewswire)
Aug-14-23 04:01PM	OptimizeRx Reports Second Quarter 2023 Financial Results (GlobeNewswire) -27.76%
Aug-10-23 06:57AM	Positive Signs As Multiple Insiders Buy OptimizeRx Stock (Simply Wall St.)
Jul-31-23 08:01AM	OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4:30 p.m. ET (GlobeNewswire)
Jun-30-23 10:52AM	OptimizeRx Corporation (NASDAQ:OPRX) is a favorite amongst institutional investors who own 85% (Simply Wall St.)
Jun-20-23 08:00AM	LifeMD Appoints William J. Febbo to its Board of Directors (GlobeNewswire)
May-24-23 07:30AM	OptimizeRxs CEO Provides 2023 Midyear Strategic Update (GlobeNewswire) +11.70%
May-23-23 07:51PM	Down More Than 50%: These 3 Beaten-Down Stocks Could Stage a Strong Rebound, Analysts Say (TipRanks)
May-18-23 09:00AM	Revenues Tell The Story For OptimizeRx Corporation (NASDAQ:OPRX) (Simply Wall St.)
08:01AM	OptimizeRxs Karina Castagna Named One of the 2023 PM360 ELITE 100 (GlobeNewswire)
May-15-23 08:00AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-10-23 05:15PM	OptimizeRx Corp. (OPRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -5.46%
04:01PM	OptimizeRx Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-04-23 06:38AM	Investing in OptimizeRx (NASDAQ:OPRX) five years ago would have delivered you a 114% gain (Simply Wall St.)
May-02-23 08:00AM	Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance (GlobeNewswire)
Apr-26-23 08:00AM	OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET (GlobeNewswire)

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lang James Paul	Director	Mar 14 '25	Buy	7.60	321,408	2,443,761	389,452	Mar 19 07:40 PM
Silvestro Stephen L	Chief Commercial Officer	Mar 01 '25	Option Exercise	0.00	1,928	0	121,886	Mar 04 09:18 AM
Odence-Ford Marion	Chief Legal Officer & CHRO	Mar 01 '25	Option Exercise	0.00	771	0	70,544	Mar 04 09:16 AM
KLEMA CATHY	Director	Feb 02 '25	Option Exercise	0.00	5,109	0	11,752	Feb 04 06:50 PM
Odence-Ford Marion	General Counsel and CCO	Dec 19 '24	Option Exercise	0.00	3,927	0	28,383	Dec 20 07:48 PM
Silvestro Stephen L	Chief Commercial Officer	Dec 19 '24	Option Exercise	0.00	6,546	0	83,424	Dec 20 07:47 PM
Besch Doug	Chief Product Officer	Dec 19 '24	Option Exercise	0.00	1,964	0	12,160	Dec 20 07:47 PM
Stelmakh Edward	CFO/COO	Dec 19 '24	Option Exercise	0.00	5,237	0	38,603	Dec 20 07:46 PM
FEBBO WILLIAM J	CEO	Dec 12 '24	Buy	5.01	20,000	100,220	601,253	Dec 16 02:28 PM
Odence-Ford Marion	General Counsel and CCO	Nov 08 '24	Option Exercise	0.00	1,785	0	24,980	Nov 12 09:37 AM
Stelmakh Edward	CFO/COO	Oct 11 '24	Option Exercise	0.00	8,222	0	35,432	Oct 15 04:53 PM
Stelmakh Edward	CFO/COO	Oct 03 '24	Option Exercise	0.00	16,622	0	31,387	Oct 07 09:30 PM
Odence-Ford Marion	General Counsel and CCO	Oct 03 '24	Option Exercise	0.00	6,649	0	25,147	Oct 07 09:26 PM
Silvestro Stephen L	Chief Commercial Officer	Oct 03 '24	Option Exercise	0.00	6,649	0	79,495	Oct 07 09:24 PM
Besch Doug	Chief Product Officer	Oct 03 '24	Option Exercise	0.00	3,324	0	11,172	Oct 07 09:24 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OPRX

OptimizeRx Corp

Upgrade your FINVIZ experience